Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.

导出原文传递

翻译打印收藏纠错

作者： Petsch, B. ^[1] ; Schnee, M. ^[2] ; Vogel, A. B. ^[3] ; Lange, E. ^[4] ; Hoffmann, B. ; Voss, D. ; Schlake, T. ; Thess, A. ; Kallen, K. J. ; Stitz, L. ; Kramps, T.

作者单位： CureVac GmbH, Tübingen, Germany ^[1] Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany ^[2] Institute of Immunology, Friedrich-Loeffler-Institut, Tübingen, Germany ^[3] Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany ^[4]

发布时间 2013-12-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Nature biotechnology

2012年30卷12期

1210-1216页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.

Nature biotechnology

相似文献

Nature biotechnology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.

Nature biotechnology

相似文献

Nature biotechnology

相关期刊

检索历史清除